SCHEMBL4547446

SCHEMBL4547446

CN(C)N1CCN(c2ccc(-c3cc(Oc4ccc5nc(N[C@@H]6CCCC[C@H]6O)sc5c4)ccn3)cn2)CC1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 17/20 0.58
PDGFRB P09619 8/20 0.58
KIT P10721 7/20 0.58
PDGFRA P16234 7/20 0.58
FLT3 P36888 7/20 0.58
WNT3A P56704 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2676708 0.92 CSF1R (0.60) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL2675951 0.92 CSF1R (0.62) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL2676241 0.91 CSF1R (0.58) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL2678035 0.91 CSF1R (0.61) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL2675471 0.90 CSF1R (0.60) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL2677425 0.90 CSF1R (0.58) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL2676898 0.90 CSF1R (0.59) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL2677966 0.89 CSF1R (0.58) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL2677721 0.89 CSF1R (0.57) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL2677651 0.89 CSF1R (0.57) CSF1RPDGFRBKITPDGFRAFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173689-B2 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling NOVARTIS AG (CH) 2012-05-08 US disclosed
US-8173689-B2 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling NOVARTIS AG (CH) 2012-05-08 US disclosed